Journey Medical Corp (DERM) Shareholders’ equity 2020–2025
Journey Medical Corp (DERM) shareholders’ equity at each fiscal year-end, per SEC filings.
$31.9MFY2025 · since FY2020: $10.3M → $31.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.9M | +58.7% |
| FY2024 | $20.1M | -1.4% |
| FY2023 | $20.4M | +19.8% |
| FY2022 | $17.0M | -59.6% |
| FY2021 | $42.0M | +308.5% |
| FY2020 | $10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice